Literature DB >> 18304732

Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43.

Hai-Xin Zhang1, Kunikazu Tanji, Fumiaki Mori, Koichi Wakabayashi.   

Abstract

TDP-43 is now known to be a major component of ubiquitin-positive, tau-negative inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions and sporadic amyotrophic lateral sclerosis. In this study, we mapped the epitope for the monoclonal anti-TDP-43 antibody 2E2-D3. Our mapping and peptide competition experiments showed that the antibody reacted with human TDP-43, but not mouse or rat TDP-43, and recognized amino acids 205-222 of human TDP-43, corresponding to a part of the second RNA recognition motif. These findings suggest that 2E2-D3 is a useful antibody for the characterization of mouse lines transgenic for human TDP-43.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304732     DOI: 10.1016/j.neulet.2008.01.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.

Authors:  Kunikazu Tanji; Fumiaki Mori; Katsumi Kito; Akiyoshi Kakita; Junsei Mimura; Ken Itoh; Hitoshi Takahashi; Tetsu Kamitani; Koichi Wakabayashi
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

2.  Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.

Authors:  Cyntia Tremblay; Isabelle St-Amour; Julie Schneider; David A Bennett; Frédéric Calon
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

3.  Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.

Authors:  Ya-Fei Xu; Tania F Gendron; Yong-Jie Zhang; Wen-Lang Lin; Simon D'Alton; Hong Sheng; Monica Castanedes Casey; Jimei Tong; Joshua Knight; Xin Yu; Rosa Rademakers; Kevin Boylan; Mike Hutton; Eileen McGowan; Dennis W Dickson; Jada Lewis; Leonard Petrucelli
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

4.  TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.

Authors:  Kunikazu Tanji; Tetsu Kamitani; Fumiaki Mori; Akiyoshi Kakita; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

5.  Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.

Authors:  Yoshinori Nishimoto; Daisuke Ito; Takuya Yagi; Yoshihiro Nihei; Yoshiko Tsunoda; Norihiro Suzuki
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

6.  Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.

Authors:  Penelope G Foulds; Yvonne Davidson; Manjari Mishra; David J Hobson; Kirsty M Humphreys; Mark Taylor; Nancy Johnson; Sandra Weintraub; Haruhiko Akiyama; Tetsuaki Arai; Masato Hasegawa; Eileen H Bigio; Fiona E Benson; David Allsop; David M A Mann
Journal:  Acta Neuropathol       Date:  2009-10-13       Impact factor: 17.088

7.  TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Petra Steinacker; Corinna Hendrich; Anne D Sperfeld; Sarah Jesse; Christine A F von Arnim; Stefan Lehnert; Alice Pabst; Ingo Uttner; Hayrettin Tumani; Virginia M-Y Lee; John Q Trojanowski; Hans A Kretzschmar; Albert Ludolph; Manuela Neumann; Markus Otto
Journal:  Arch Neurol       Date:  2008-11

8.  Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.

Authors:  Ya-Fei Xu; Yong-Jie Zhang; Wen-Lang Lin; Xiangkun Cao; Caroline Stetler; Dennis W Dickson; Jada Lewis; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2011-10-26       Impact factor: 14.195

Review 9.  TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies.

Authors:  Joery Goossens; Eugeen Vanmechelen; John Q Trojanowski; Virginia M Y Lee; Christine Van Broeckhoven; Julie van der Zee; Sebastiaan Engelborghs
Journal:  Acta Neuropathol Commun       Date:  2015-04-01       Impact factor: 7.801

10.  Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.

Authors:  Simon D'Alton; Marcelle Altshuler; Ashley Cannon; Dennis W Dickson; Leonard Petrucelli; Jada Lewis
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.